Argentina has only 7.5% of the vaccines it bought: which ones have arrived and which others are expected

By drops. It gives the feeling that the vaccines you bought are coming to Argentina to immunize the population and try to mitigate the effects the second hello of the pandemic on the national territory.

To date, after 88 days of immunization, the figures indicate that what the national government has called “the biggest vaccination campaign in history” is far from being.

According to official figures from the Nation’s Ministry of Health, Of the 65,470,000 vaccines acquired by the Argentine State, only 4,880,355 were received in the national territory.. From these 3,300,355 correspond to the Sputnik V vaccine (2,290,195 of the first dose and 1,010,160 of the second), 580,000 doses are of the CovidShield formulation -Oxford / Astrazeneca produced by the Serum Institute of India- and one million doses of Chinese Sinopharm vaccine.

To those, as they informed him Infobae the sources of the health portfolio, There will be added 370,000 doses of component 1 of Sputnik V which will arrive today in the country and 218,000 of that prepared by the University of Oxford and the AstraZeneca laboratory, which will arrive on Sunday via the COVAX mechanism..

The latter should arrive early on the 28th on a flight from the airline KLM. This first shipment is part of the 9 million doses that the country has committed through the mechanism of the World Health Organization (WHO), an initiative aimed at guaranteeing fair and equitable access to vaccines for all countries of the world.

In this regard, before consulting this environment, the physician specializing in infectious diseases Roberto Debbag (MN 60.253) noted that “Something is happening in the world because of the problems laboratories have with production volumes and it is that this exposes three types of countries.”. Thus, for the vice-president of the Latin American Society of Pediatric Infectology, “there are the industrialized countries, which will have access to the doses they need, the nations with the lowest GDP, which can benefit from an action. of solidarity, and a third group of intermediate countries, including Argentina, which will depend on the agreements they conclude ”.

The truth is that 90% of global vaccine production is in the hands of 10% of countries.

Given the scarcity of this essential intake and the proximity of the cold season, one of the options considered is the possibility of postponing the second dose in order to vaccinate more people with the first. The alternative is currently being evaluated by the Nation’s Ministry of Health and the National Vaccination Commission, as vaccines authorized today in Argentina are administered in two doses at different intervals to ensure total protection. In the case of Sputnik V, the first dose is different from the second dose. As for the other vaccines, “official data is still lacking on the second dose of the AstraZeneca vaccine with the Indian Institute, which is called Covishield.”

In this sense, Debbag clarified that “In Argentina, at least 15 million doses are needed to deliver the first dose to at least 7.4 million over 60 years and to about 5 million people with co-morbidities.”. “If this universe of about 13 million people is vaccinated, mortality decreases, which is ultimately what is sought,” he said.

According to the Public Vaccination Monitor, the online registry of the Ministry of Health which shows the vaccination operation in real time throughout Argentina, this morning, 3474,415 vaccines are already applied, 2,824,344 people received the first dose and 650,071 both.

KEEP READING